Concepedia

S. Aubrey Stoch

SA

Statistics

Publications

39

Citations

1.8K

H-Index

22

Active since

1992

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Celerion (United States)

MSD (Belgium)

Covance (United States)

Ghent University Hospital

S. Aubrey Stoch is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1992–2023

39

Publications

39

Bone Loss in Men with Prostate Cancer Treated with Gonadotropin-Releasing Hormone Agonists<sup>1</sup>

S. Aubrey Stoch, Robert A. Parker, Liping Chen et al. · The Journal of Clinical Endocrinology & Metabolism · 2001 · 186 citations · Full text

, , +17

Pitavastatin is a more sensitive and selective organic anion‐transporting polypeptide<scp>1B</scp>clinical probe than rosuvastatin

Thomayant Prueksaritanont, Xiaoyan Chu, Raymond Evers et al. · British Journal of Clinical Pharmacology · 2014 · 162 citations · Full text

Effect of the Cathepsin K Inhibitor Odanacatib on Bone Resorption Biomarkers in Healthy Postmenopausal Women: Two Double-Blind, Randomized, Placebo-Controlled Phase I Studies

S. Aubrey Stoch, Stefan Zajic, Julie A. Stone et al. · Clinical Pharmacology & Therapeutics · 2009 · 156 citations

Effect of L-000845704, an αVβ3 Integrin Antagonist, on Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporotic Women

M. Gail Murphy, K. Cerchio, S. Aubrey Stoch et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 136 citations · Full text

Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor

Douglas G. Johns, Louis‐Charles Campeau, Puja Banka et al. · Circulation · 2023 · 118 citations · Full text

1–5 of 39